Skip to search formSkip to main contentSkip to account menu

NC 1800

Known as: NC-1800 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

MorpholinesOxazolidinones

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
ネコの膀胱内圧および尿道外括約筋活動に及ぼすアルキレンジアミン誘導体 (±)-(5RS)-5-benzyl-3-[(1SR)-3-morpholino-1-phenylpropyl]-1,3-oxazolidin-2-one monofumarate (NC-1800) の影響
1999
1999
Synthesis of optically active NC-1800, a therapeutic agent for urinary disturbance.
A new synthetic method for chiral oxazolidinone derivatives, therapeutic agents for treating urinary disturbance, is described… 
1999
1999
Therapeutic agent for treating dysuria (NC-1800): absolute configuration of the enantiomers.
The absolute configuration of an enantiomer of the title compound, (+/-)-1. fumaric acid salt, was determined by X-ray… 
1997
1997
Central effects of (5RS, 1'SR)-5-benzyl-3-(3'-morpholino-1'-phenylpropyl)-1,3-oxazolidin-2 -one monofumarate on the function of the bladder and periurethral skeletal muscle in anesthetized rats.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)